Sort
15,273 grants matching “antimicrobial resistance”
Identification of novel MDR antimicrobials from human microbiome symbioses
$1,115,616Nasia Safdar · University Of Wisconsin-Madison · U19 · FY2020 · AI
Advanced Development of a Combined Shigella-ETEC Vaccine
$1,115,547Eileen M. Barry · University Of Maryland Baltimore · R01 · FY2024 · AI
Oxadiazole Inhibitors of Non-Stop Ribosome Rescue to treat MDR Neisseria gonorrhoeae
$1,114,898Zachary David Aron · Microbiotix, Inc · R01 · FY2018 · AI
Exploiting Riboswitch Sensors to Reveal Antibiotics Uptake and Retention in Gram Negative Bacteria
$1,114,844Ronald R Breaker · Yale University · R01 · FY2020 · AI
IMPDH-targeted antibiotics for select agents
$1,114,349Lizbeth K. Hedstrom · Brandeis University · R01 · FY2011 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,114,342Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance
$1,112,000Anthony Bernard Schryvers · University Of Calgary · R01 · FY2019 · AI
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$1,110,653Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Innovative technologies to transform antibiotic discovery. Project 3 Rapid Access to Antibiotic Biosynthesis Machinery Using Synthetic Biology
$1,109,686Robert Nicol · Broad Institute, Inc. · U19 · FY2023 · AI
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.
$1,109,538Betty B Wu · Talis Biomedical Corporation · R01 · FY2021 · AI
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.
$1,109,538Kyle Andrew Tipton · Talis Biomedical Corporation · R01 · FY2020 · AI
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.
$1,109,538Betty B Wu · Talis Biomedical Corporation · R01 · FY2022 · AI
Short and long term outcomes of doxycycline versus TMP-SMX for SSTI treatment
$1,107,689Loren G Miller · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2019 · AI
Consortium for drug-resistant Gram-negative pathogen detection
$1,106,988Lee W Riley · University Of California Berkeley · R01 · FY2018 · AI
Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia
$1,106,914Sophia Koo · Brigham And Women'S Hospital · R01 · FY2023 · AI
Short and long term outcomes of doxycycline versus TMP-SMX for SSTI treatment
$1,106,595Loren G Miller · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2020 · AI
CONTROL OF PERIODONTAL INFECTIONS
$1,106,416Forsyth Institute · P01 · FY2000 · DE
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.
$1,106,115Martin Goldberg · Talis Biomedical Corporation · R01 · FY2019 · AI
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity
$1,106,000Robin Knight · University Of California, San Diego · DP1 · FY2023 · AT
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity
$1,106,000Robin Knight · University Of California, San Diego · DP1 · FY2022 · AT
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity
$1,106,000Robin Knight · University Of California, San Diego · DP1 · FY2021 · AT
Centers for Research on Structural Biology of Infectious Diseases: Antibacterial Resistance Research Activities
$1,105,338Karla Satchell · Northwestern University At Chicago · N01 · FY2025 · AI
Centers for Research on Structural Biology of Infectious Diseases: Antibacterial Resistance Research Activities
$1,105,338Bart Staker · Seattle Children'S Hospital · N01 · FY2025 · AI
Micro_patterned Surfaces for Reducing the Risk of Ventilator_Associated Pneumonia
$1,105,112Shravanthi Reddy · Sharklet Technologies, Inc. · R44 · FY2013 · HL
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity
$1,102,792Robin Knight · University Of California, San Diego · DP1 · FY2020 · AT